Your browser doesn't support javascript.
loading
A novel rituximab administration protocol to minimize infusion-related adverse reactions in patients with B-cell lymphoma.
Tsutsumi, Daisuke; Hayama, Tatsuya; Miura, Katsuhiro; Uchiike, Akihiro; Tsuboi, Shinya; Otsuka, Susumu; Hatta, Yoshihiro; Kishikawa, Yukinaga.
Affiliation
  • Tsutsumi D; Laboratory of Clinical Pharmacy, Nihon University School of Pharmacy, 7-7-1 Narashinodai, Funabashi City, Chiba, 274-8555, Japan.
  • Hayama T; Department of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi City, Tokyo, 173-8610, Japan.
  • Miura K; Department of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi City, Tokyo, 173-8610, Japan.
  • Uchiike A; Tumor Center, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi City, Tokyo, 173-8610, Japan.
  • Tsuboi S; Tumor Center, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi City, Tokyo, 173-8610, Japan. miura.katsuhiro@nihon-u.ac.jp.
  • Otsuka S; Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi City, Tokyo, 173-8610, Japan. miura.katsuhiro@nihon-u.ac.jp.
  • Hatta Y; Laboratory of Clinical Pharmacy, Nihon University School of Pharmacy, 7-7-1 Narashinodai, Funabashi City, Chiba, 274-8555, Japan.
  • Kishikawa Y; Department of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi City, Tokyo, 173-8610, Japan.
Int J Clin Pharm ; 44(2): 366-373, 2022 Apr.
Article in En | MEDLINE | ID: mdl-34894347

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Drug-Related Side Effects and Adverse Reactions / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Clin Pharm Year: 2022 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Drug-Related Side Effects and Adverse Reactions / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Clin Pharm Year: 2022 Document type: Article Affiliation country: Japan